That's essential, since the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (future report review). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. This was a breakthrough nearly nobody discovered. However it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment chances in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (exponential tech investor). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back perhaps significantly before going higher - jeff brown 1 biotech company. I've been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. brownstone research. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the brink of striking the public markets And I have actually been working on a new method for you to invest even before these companies go public.
This opportunity has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to reserve your spot for complimentary.
Emma Walsh here, handling editor of the Journal. Routine Diary readers understand that tech isn't our typical beat (jeff brown 2020 predictions). And when it comes to tech investing, we leave it to the professionals. The good news is, we have a number of such experts in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown market predictions). In fact, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and creating amazing opportunities for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown 1 biotech. However regardless of what numerous readers might believe, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interrupted supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown tech stock 2021). Losing two months of manufacturing and sales actually affects how lots of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million systems is exceptional. More significantly, the delays triggered by the pandemic created a lot of pent-up need. Which demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - biotech stocks jeff brown. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually described its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services begin to be offered (the legacy report prediction). That's when we start to see applications operating on 5G networks. Consider things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer season. This starts something of a virtuous cycle: A lot of individuals do not actually care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of extraordinary applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities going forward will be enormous. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For years, CRISPR was mostly a niche innovation that wasn't well understood. And during that time, there were really just 3 business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire industry is successfully a greenfield chance.
There's space for many companies to exist in this space. tech predictions. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can precisely anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That's essential since the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced utilizing this innovation. This was among those breakthroughs that practically nobody saw. However it's going to have profound implications for curing disease. And, naturally, there will be lots of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back perhaps considerably prior to going greater. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - angel investor. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. melania trump. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date since February 2021, however we might not independently confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding viewpoint on the market. He's constantly on the hunt for new chances, and he shares a lot of his finest choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted a few of the most significant financial events of the past 20 years. Although he doesn't appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, however Jeff Brown's accurate forecasts have made him legions of devoted fans. That states a lot about his ability. The Future Report is published by Brownstone Research, a prominent monetary research study publisher. Brownstone Research offers numerous research services with a wide variety of expertises - jeff brown biotech picks.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - tech predictions. On its website, Brownstone says its mission is to supply retail financiers with professional-grade research study: "For too long, the very best investment research has not been readily available to individual financiers. It has been usually booked for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown stock predictions. The mission of Brownstone Research is to make that kind of proprietary research available to any investors aiming to gain an edge in the marketplaces. The objective is simple to provide unique and profitable investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. tech predictions. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. jeff brown 2021 stock picks. might be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 innovative technologies: expert system and electric cars and trucks. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automotive industry's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have actually been huge this year, but the Wall Street machine has actually approved hype without much concrete outcome. Despite a drastic boost in competitors over the previous few years, Brown still thinks Musk has the very best possibility of putting it all together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Generally, this innovation would permit you to lease out your car as an autonomous, self-driving taxi when you're not using it. You simply leave the vehicle and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the earnings. It sounds outrageous, however it could be closed than you think.